Influenza Vaccine Market Segmentation:
End user Segment Analysis
Government programs is leading and is anticipated to hold a market share of 45.7% by 2037. The post-pandemic preparation is one of the key aspects that led to the growth of the government programs for immunization in the global market. The EU and U.S. have undertaken the government policy to stockpile the flu vaccine as an important part of their national biosecurity of the nation. Free distribution of dosage of influenza vaccine is initiated by the government like India and Indonesia to elevate public health. Subsidies are also delivered for the influenza vaccine for the aged population in Japan and China, that accelerated the market demand.
Type Segment Analysis
Quadrivalent vaccines dominate the sub-segment and are projected to grow with a market share hold of 42.5% by 2037. According to the report of the Centers for Disease Control and Prevention, the quadrivalent vaccine provides superior strain coverage. This has resulted in a reduction of hospital stays by 24% and saved health expenses. The medical coverage is expanded for the quadrivalent vaccine the ensuring higher patient accessibility. As per the report of CMS, over 95% of the Medicaid coverage is ensured for the quadrivalent vaccines, which expanded the adoption rate in the U.S. market.
Our in-depth analysis of the global influenza vaccine market includes the following segments:
|
Segment |
Subsegment |
|
End user |
|
|
Type |
|
|
Age Group |
|
